富瀚微(300613) - 2022 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2022 reached ¥514,629,466.49, representing a 142.88% increase compared to ¥211,884,389.64 in the same period last year[4] - Net profit attributable to shareholders was ¥101,601,138.19, a significant increase of 192.96% from ¥34,681,346.65 in the previous year[4] - Basic earnings per share rose to ¥0.85, up 193.10% from ¥0.29 in the previous year[4] - The net profit for Q1 2022 was CNY 93,107,945.93, up from CNY 35,314,706.24 in Q1 2021, reflecting a growth of approximately 164%[33] - The total comprehensive income attributable to the parent company was CNY 101,601,138.19, compared to CNY 34,681,346.65 in the previous period, reflecting a significant increase[40] Cash Flow and Liquidity - The net cash flow from operating activities improved to ¥98,992,718.50, a 176.05% increase from a negative cash flow of -¥130,176,492.22 in the same period last year[4] - Cash inflows from operating activities totaled CNY 579,460,873.52, compared to CNY 213,423,407.11 in the previous period, showing a strong increase in cash generation[43] - The ending cash and cash equivalents balance increased to CNY 850,614,242.22 from CNY 415,769,888.44 in the previous period, demonstrating improved liquidity[50] - The company reported a net increase in cash and cash equivalents of CNY 51,720,738.48, contrasting with a decrease of CNY 354,198,029.81 in the previous period, indicating better cash management[50] Assets and Liabilities - Total assets at the end of Q1 2022 were ¥2,939,621,149.64, a 1.01% increase from ¥2,910,330,581.72 at the end of the previous year[4] - The total liabilities decreased to CNY 750,340,193.10 from CNY 816,433,484.38, indicating a reduction of approximately 8%[29] - The equity attributable to shareholders of the parent company increased to CNY 1,939,328,271.83 from CNY 1,835,451,220.37, reflecting a growth of about 5.7%[29] Research and Development - The company reported a 56.82% increase in R&D expenses, totaling ¥61,651,565.15, compared to ¥39,313,823.03 in the same period last year[8] - The R&D expenses for Q1 2022 were CNY 61,651,565.15, compared to CNY 39,313,823.03 in the previous year, showing an increase of about 57%[33] - The company plans to continue investing in R&D and expanding its market presence, although specific future projections were not detailed in the report[30] Shareholder Information - The total number of common shareholders at the end of the reporting period is 20,047, with the top 10 shareholders holding a combined 53.95% of shares[12] - Tibet Oriental Qihui Investment Co., Ltd. holds 15.90% of shares, while Chen Chunmei holds 13.44%[12] Investment Activities - The company has invested RMB 80 million in Jiangyin Hanlian Zhixin Equity Investment Partnership, which has completed its private fund registration[20] - The company received CNY 30,000,000.00 from investment recoveries, showing active management of investment portfolios[47] Operational Efficiency - The company experienced a 611.77% increase in tax and additional fees, amounting to ¥2,710,410.05, up from ¥380,801.15 in the previous year[8] - The company reported a significant increase in accounts payable, which decreased from CNY 122,986,377.43 to CNY 103,659,977.51, a reduction of approximately 16%[29] - Cash outflows for investing activities amounted to CNY 72,798,548.13, down from CNY 268,715,820.47 in the previous period, indicating a reduction in investment expenditures[47] - The net cash flow from financing activities was negative CNY 1,670,263.01, compared to a positive CNY 45,471,092.98 in the previous period, reflecting changes in financing strategy[50]